Biggest News Aggregation in the World
📰 Solomon Langermann News

Solomon Langermann News Today

Fast, Ad-Free News Updates

Stay updated with breaking news from Solomon Langermann. Real-time updates on events, politics, business and more.

Preclinical Data Demonstrate Anti-Siglec-15 Treatment Reduced Bone Loss and Enhanced Bone Quality in Mice with Moderate-to-Severe Osteogenesis Imperfecta (OI)

Data Presented at the 2023 American Society for Bone and Mineral Research Annual MeetingBELTSVILLE, Md., Oct. 17, 2023 -- NextCure, Inc. , a clinical-stage biopharmaceutical company committed to...
United States Hospital For Special Surgery New York Timothy Mayer Cathleen Raggio Exchange Commission

A Phase 2 Study of Anti-Siglec-15 Antibody, NC318, in Combination with Pembrolizumab (NCT04699123) Demonstrates Clinical Activity in Patients with Advanced PD-1 Axis Inhibitor Refractory NSCLC

• Data presented at the 2023 World Conference on Lung Cancer hosted by the International Association for the Study of Lung Cancer in Singapore BELTSVILLE, Md., Sept. 12, 2023 -- NextCure,...
Timothy Mayer Lieping Chen Roy Herbst Yale Cancer Center Yale School Of Medicine Nextcure Inc

Stay Updated with Latest News

Get breaking news updates delivered to your inbox

Browse All News →

NextCure Presents Non-Clinical Data Defining the Mechanism of NC525 at the 2023 Federation of Clinical Immunology Societies (FOCIS) Annual Meeting

BELTSVILLE, Md., June 21, 2023 (GLOBE NEWSWIRE) -- NextCure, Inc. (Nasdaq: NXTC), a clinical-stage biopharmaceutical company committed to discovering and developing novel, first-in-class immunomedicines to treat cancer and other immune-related dise...
United States Timothy Mayer Nextcure Inc Federation Of Clinical Immunology Societies Exchange Commission Clinical Immunology Societies

Explore More Categories

World News India News Business Technology Sports Entertainment Health Science